Response by Singfer and Defreyne to Letter Regarding Article, "Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients"
Stroke. 2018 Mar;49(3):e137.
doi: 10.1161/STROKEAHA.118.020396.
Epub 2018 Feb 13.